Pharmacoepidemiology and Therapeutic Risk Management study the use, benefits, and risks of medicines in large populations. This field combines epidemiological methods with pharmacology to assess drug safety, effectiveness, and patterns of use in real-world settings. In public health, it plays a vital role in monitoring adverse drug reactions, evaluating long-term medication outcomes, and ensuring patient safety. Therapeutic risk management focuses on identifying, minimizing, and communicating risks associated with medicines through surveillance systems, risk mitigation strategies, and regulatory oversight. These activities are especially important during mass drug use and public health emergencies. Evidence generated through pharmacoepidemiology informs prescribing guidelines, regulatory decisions, and health policy. By promoting safe and effective medicine use, this field strengthens healthcare quality, protects populations, and supports rational, evidence-based therapeutic practices.
Title : Artificial radionuclides and evolutionary mismatch: Vulnerability of the colon, pancreas, diabetes, and arteries
Sebastiano Venturi, Department of Public Health of Rimini, Italy
Title : Specific strategies over the life course for early identification, prevention, treatment, and long-term support
Christopher Ashton, Center for Recovery, Canada
Title : Population health, public health and the social determinants of health: The state of the science
Adele Ann Webb, Strategic Education, Inc., United States
Title : The nutritional management of healthy menu plans
Iuliana Vintila, Dunărea de Jos University of Galați, Romania
Title : Healthcare system profiles and pandemic outcomes: A cross-country multi-dimensional scaling analysis of Cuba, Spain, Italy, and Germany
Giuseppe Orlando, University of Bari Aldo Moro, Italy
Title : Change your genes – change your life: Epigenetics of longevity
Kenneth R Pelletier, USCF School of Medicine, United States